Marco Gobbi

Citada per

	Totes	Des de 2020
Citacions	11878	3661
Índex h	54	34
Índex i10	158	76

740

370

185

555

199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202552 71 39 59 59 90 103 156 142 137 133 147 187 198 198 191 201 211 326 411 507 604 635 598 655 676 583 621 725 692 731 682 692 131

Accés públic

Mostra-ho tot

54 articles

1 article

disponibles

no disponibles

Es basa en els requisits de les agències que proporcionen el finançament

Coautors

Mario SalmonaCapo del Dipartimento di Biochimica e Farmacologia MolecolareCorreu electrònic verificat a marionegri.it
Matteo StravalaciFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoCorreu electrònic verificat a policlinico.mi.it
Gianluigi ForloniHead of Neuroscience Department IRCCS Mario Negri, MilanCorreu electrònic verificat a marionegri.it
Jacopo LucchettiIRCCS - Istituto di Ricerche Farmacologiche "Mario Negri"Correu electrònic verificat a marionegri.it
Annamaria VezzaniIRCCS-Istituto di Ricerche Farmacologiche Mario NegriCorreu electrònic verificat a marionegri.it
Maria Grazia De SimoniMario NegriCorreu electrònic verificat a marionegri.it
Emiliano BiasiniDepartment of Cellular, Computational & Integrative Biology (CIBIO), University of Trento, ITALYCorreu electrònic verificat a unitn.it
Roberto ChiesaLaboratory of Prion Neurobiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, MilanCorreu electrònic verificat a marionegri.it
Fabrizio TagliaviniFondazione IRCCS Istituto Neurologico Carlo Besta, MilanoCorreu electrònic verificat a istituto-besta.it
Alberto MantovaniDirettore Scientifico, Istituto Clinico Humanitas, Humanitas UniversityCorreu electrònic verificat a humanitasresearch.it
Elisa R ZanierDepartment of Acute Brain and Cardiovascular Injury, Mario Negri Institute IRCCSCorreu electrònic verificat a marionegri.it
Marcella CataniaU.O. Neurologia 5 - Neuropatologia, Fondazione IRCCS - Istituto Neurologico Carlo BestaCorreu electrònic verificat a istituto-besta.it
Silvano SozzaniProfessor of Pathology, Sapienza University of RomeCorreu electrònic verificat a uniroma1.it
Claudia ManzoniUniversity of ReadingCorreu electrònic verificat a ucl.ac.uk
barbara bottazziIstituto Clinico HumanitasCorreu electrònic verificat a humanitasresearch.it
Couvreur PUniversité Paris-SaclayCorreu electrònic verificat a universite-paris-saclay.fr
Julien NICOLASCNRS Research Director, Univ Paris-Saclay. Twitter: @julnicolasCorreu electrònic verificat a universite-paris-saclay.fr
Massimo LocatiUniversity of MilanCorreu electrònic verificat a unimi.it

Segueix

Marco Gobbi

Istituto di Ricerche Farmacologiche Mario Negri IRCCS

Correu electrònic verificat a marionegri.it - Pàgina d'inici

biochemistry pharmacology neuroscience


Títol Ordena per cites Ordena per any Ordena per títol	Citada per Citada per	Any
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein C Balducci, M Beeg, M Stravalaci, A Bastone, A Sclip, E Biasini, L Tapella, ... Proceedings of the National Academy of Sciences 107 (5), 2295-2300, 2010	610	2010
Regulation of leukocyte recruitment by the long pentraxin PTX3 L Deban, RC Russo, M Sironi, F Moalli, M Scanziani, V Zambelli, ... Nature immunology 11 (4), 328-334, 2010	510	2010
A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis G Di Fede, M Catania, M Morbin, G Rossi, S Suardi, G Mazzoleni, ... Science 323 (5920), 1473-1477, 2009	510	2009
Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. S Sozzani, W Luini, A Borsatti, N Polentarutti, D Zhou, L Piemonti, ... Journal of immunology (Baltimore, Md.: 1950) 159 (4), 1993-2000, 1997	465	1997
Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1 E Fumagalli, M Funicello, T Rauen, M Gobbi, T Mennini European journal of pharmacology 578 (2-3), 171-176, 2008	294	2008
Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis M Morigi, M Galbusera, S Gastoldi, M Locatelli, S Buelli, A Pezzotta, ... The Journal of Immunology 187 (1), 172-180, 2011	288	2011
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide S Mourtas, M Canovi, C Zona, D Aurilia, A Niarakis, B La Ferla, ... Biomaterials 32 (6), 1635-1645, 2011	280	2011
Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6 AM Fra, M Locati, K Otero, M Sironi, P Signorelli, ML Massardi, M Gobbi, ... The Journal of Immunology 170 (5), 2279-2282, 2003	267	2003
Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study L Obici, A Cortese, A Lozza, J Lucchetti, M Gobbi, G Palladini, S Perlini, ... Amyloid 19 (sup1), 34-36, 2012	260	2012
The antidepressant mechanism of Hypericum perforatum T Mennini, M Gobbi Life sciences 75 (9), 1021-1027, 2004	246	2004
Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide M Gobbi, F Re, M Canovi, M Beeg, M Gregori, S Sesana, S Sonnino, ... Biomaterials 31 (25), 6519-6529, 2010	245	2010
Carrier‐dependent and Ca2+‐dependent 5‐HT and dopamine release induced by (+)‐amphetamine, 3, 4‐methylendioxy‐methamphetamine, p‐chloroamphetamine and (+)‐fenfluramine D Crespi, T Mennini, M Gobbi British journal of pharmacology 121 (8), 1735-1743, 1997	234	1997
An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo BR Fluharty, E Biasini, M Stravalaci, A Sclip, L Diomede, C Balducci, ... Journal of Biological Chemistry 288 (11), 7857-7866, 2013	222	2013
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial S Haïk, G Marcon, A Mallet, M Tettamanti, A Welaratne, G Giaccone, ... The Lancet Neurology 13 (2), 150-158, 2014	210	2014
Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy F Noè, AH Pool, J Nissinen, M Gobbi, R Bland, M Rizzi, C Balducci, ... Brain 131 (6), 1506-1515, 2008	206	2008
PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer’s disease D Brambilla, R Verpillot, B Le Droumaguet, J Nicolas, M Taverna, J Kona, ... ACS nano 6 (7), 5897-5908, 2012	204	2012
Development of a proteolytically stable retro-inverso peptide inhibitor of β-amyloid oligomerization as a potential novel treatment for Alzheimer’s disease M Taylor, S Moore, J Mayes, E Parkin, M Beeg, M Canovi, M Gobbi, ... Biochemistry 49 (15), 3261-3272, 2010	193	2010
Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor R Bonecchi, M Locati, E Galliera, M Vulcano, M Sironi, AM Fra, M Gobbi, ... The Journal of Immunology 172 (8), 4972-4976, 2004	177	2004
Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer’s disease B Le Droumaguet, J Nicolas, D Brambilla, S Mura, A Maksimenko, ... ACS nano 6 (7), 5866-5879, 2012	172	2012
Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury S Papa, F Rossi, R Ferrari, A Mariani, M De Paola, I Caron, F Fiordaliso, ... ACS nano 7 (11), 9881-9895, 2013	168	2013

En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.

Articles 1–20

Cites per any

Cites duplicades

Cites combinades

Addició de coautorsCoautors

Segueix

Citada per

Coautors